Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	CAPN9 HSPG2 CAPN14 CDHR1 ANXA4 FAT3 PCDHB14 LCP1 ITGB1 FSCB CAPN11 S100A11 PKD2L2 CANT1 RPTN PLA2G5 SDF4 EGFLAM	3.89e-05	749	162	18	GO:0005509
GeneOntologyMolecularFunction	mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity	MAN2A2 MAN2A1	6.54e-05	2	162	2	GO:0004572
GeneOntologyMolecularFunction	phenanthrene-9,10-epoxide hydrolase activity	AKR7L AKR7A3	1.95e-04	3	162	2	GO:0019119
GeneOntologyMolecularFunction	phenanthrene-epoxide hydrolase activity	AKR7L AKR7A3	1.95e-04	3	162	2	GO:0019118
GeneOntologyMolecularFunction	calcium-dependent cysteine-type endopeptidase activity	CAPN9 CAPN14 CAPN11	3.28e-04	17	162	3	GO:0004198
GeneOntologyBiologicalProcess	N-glycan processing	MAN2A2 MAN2A1 ST8SIA6 ST8SIA5	7.48e-06	17	159	4	GO:0006491
Domain	THIOL_PROTEASE_CYS	CAPN9 CAPN14 CAPN11 CTSZ	6.37e-05	26	158	4	PS00139
Domain	Endosulphine	ARPP19 ENSA	7.11e-05	2	158	2	IPR006760
Domain	Endosulfine	ARPP19 ENSA	7.11e-05	2	158	2	PF04667
Domain	THIOL_PROTEASE_ASN	CAPN9 CAPN14 CAPN11 CTSZ	7.43e-05	27	158	4	PS00640
Domain	THIOL_PROTEASE_HIS	CAPN9 CAPN14 CAPN11 CTSZ	7.43e-05	27	158	4	PS00639
Domain	Pept_cys_AS	CAPN9 CAPN14 CAPN11 CTSZ	8.62e-05	28	158	4	IPR000169
Domain	Laminin_G_1	HSPG2 LAMA1 EGFLAM	9.32e-05	11	158	3	PF00054
Domain	calpain_III	CAPN9 CAPN14 CAPN11	1.24e-04	12	158	3	SM00720
Domain	C2_III	CAPN9 CAPN14 CAPN11	1.24e-04	12	158	3	IPR033883
Domain	Calpain_III	CAPN9 CAPN14 CAPN11	1.24e-04	12	158	3	IPR022683
Domain	Calpain_III	CAPN9 CAPN14 CAPN11	1.60e-04	13	158	3	PF01067
Domain	Calpain_domain_III	CAPN9 CAPN14 CAPN11	1.60e-04	13	158	3	IPR022682
Domain	Calpain_cysteine_protease	CAPN9 CAPN14 CAPN11	2.02e-04	14	158	3	IPR022684
Domain	Peptidase_C2	CAPN9 CAPN14 CAPN11	2.51e-04	15	158	3	PF00648
Domain	CysPc	CAPN9 CAPN14 CAPN11	2.51e-04	15	158	3	SM00230
Domain	Peptidase_C2_calpain_cat	CAPN9 CAPN14 CAPN11	2.51e-04	15	158	3	IPR001300
Domain	CALPAIN_CAT	CAPN9 CAPN14 CAPN11	2.51e-04	15	158	3	PS50203
Domain	LAM_G_DOMAIN	HSPG2 FAT3 LAMA1 EGFLAM	2.91e-04	38	158	4	PS50025
Domain	Laminin_G_2	HSPG2 FAT3 LAMA1 EGFLAM	3.55e-04	40	158	4	PF02210
Domain	LamG	HSPG2 FAT3 LAMA1 EGFLAM	5.14e-04	44	158	4	SM00282
Domain	Glyco_hydro_38_C	MAN2A2 MAN2A1	6.99e-04	5	158	2	IPR011682
Domain	Alpha-mann_mid	MAN2A2 MAN2A1	6.99e-04	5	158	2	PF09261
Domain	Glyco_hydro_57/38_cen	MAN2A2 MAN2A1	6.99e-04	5	158	2	IPR028995
Domain	Glyco_hydro_38	MAN2A2 MAN2A1	6.99e-04	5	158	2	PF01074
Domain	-	MAN2A2 MAN2A1	6.99e-04	5	158	2	1.20.1270.50
Domain	-	MAN2A2 MAN2A1	6.99e-04	5	158	2	3.20.110.10
Domain	Alpha-mann_mid	MAN2A2 MAN2A1	6.99e-04	5	158	2	SM00872
Domain	Glyco_hydro_38_N	MAN2A2 MAN2A1	6.99e-04	5	158	2	IPR000602
Domain	Glyco_hydro_38/57_N	MAN2A2 MAN2A1	6.99e-04	5	158	2	IPR027291
Domain	Glyco_hydro_38_cen	MAN2A2 MAN2A1	6.99e-04	5	158	2	IPR015341
Domain	Glyco_hydro_38C	MAN2A2 MAN2A1	6.99e-04	5	158	2	PF07748
Domain	EF_Hand_1_Ca_BS	CAPN9 CAPN14 LCP1 CAPN11 S100A11 RPTN SDF4	7.32e-04	175	158	7	IPR018247
Domain	Glyco_hydro/deAcase_b/a-brl	MAN2A2 MAN2A1	1.45e-03	7	158	2	IPR011330
Domain	Laminin_G	HSPG2 FAT3 LAMA1 EGFLAM	1.47e-03	58	158	4	IPR001791
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	HSPG2 COL6A1 VWF MAN2A1 ANXA4 ARMC9 PFKL NEB LCP1 ITGB1 TIAM2 SLC5A2 MSN VPS13D IGF2R AKR7A3 C9 CTSD PRRC2A RAB27A PCYOX1	1.57e-08	1016	164	21	19056867
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	HSPG2 COL6A1 MAN2A2 MARS1 GEMIN5 PFKL ITGB1 HEPH IGF2BP1 IGF2R CTPS1 CTSD PLOD2 RAB27A CTSZ	2.45e-07	613	164	15	22268729
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HSPG2 RIN3 MAN2A2 CLTCL1 CYTH1 GEMIN5 CFAP43 GRIN2D PRAG1 TIAM2 DIP2A TNRC18 IGF2R PTPRF SBF1 CANT1 PCNX1 SDF4 TOP3B CTSZ	2.98e-07	1105	164	20	35748872
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	HSPG2 MAN2A1 LCAT ITGB1 F13B PTPRF ADGRF5 C9 CTSD PCYOX1	4.41e-07	257	164	10	16335952
Pubmed	Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).	HSPG2 COL6A1 MAN2A1 ANXA4 PFKL MSN S100A11 PTPRF SDF4 PLOD2 GALNT4 SLC6A14	7.67e-07	417	164	12	19199708
Pubmed	The N-terminal globular domain of the laminin alpha1 chain binds to alpha1beta1 and alpha2beta1 integrins and to the heparan sulfate-containing domains of perlecan.	HSPG2 LAMA1 ITGB1	1.02e-06	5	164	3	9688542
Pubmed	Expression of Nephronectin in the Descemet's membrane of mouse corneas during development and adult homeostasis.	HSPG2 COL8A2 LAMA1	1.02e-06	5	164	3	38246333
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	HSPG2 COL6A1 ABCB7 MAN2A2 MAN2A1 LAMA1 SEZ6L2 ITGB1 IGF2R PTPRF CANT1 CNPY3 SDF4 TMED2 TIMELESS CTSD PLOD2 CTSZ GALNT4 PCYOX1	1.09e-06	1201	164	20	35696571
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	RGPD8 SENP3 PFKL LCP1 MSH6 TIAL1 TUBGCP3 RBM5 CTPS1 PRRC2A FMNL1	1.64e-06	370	164	11	22922362
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	HSPG2 COL6A1 VWF ANXA4 LAMA1 S100A11 CTSD CTSZ	1.96e-06	175	164	8	28071719
Pubmed	LZTR1 is a regulator of RAS ubiquitination and signaling.	LCP1 ITGB1 HEPH MSN IGF2R SBF1 RAB27A	2.53e-06	127	164	7	30442766
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	HSPG2 COL6A1 CLTCL1 MAN2A1 ANXA4 LCAT LCP1 ITGB1 MSN S100A11 IGF2R AKR7L CANT1 AKR7A3 C9 CTSD RAB27A CTSZ	3.39e-06	1070	164	18	23533145
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	HSPG2 COL6A1 COL8A2 VWF ANXA4 CTSD CTSZ	8.67e-06	153	164	7	25037231
Pubmed	Molecular genetics of successful smoking cessation: convergent genome-wide association study results.	DPP6 CCDC73 LAMA1 SORCS1 ASTN1 ADGRF5	8.78e-06	101	164	6	18519826
Pubmed	Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins.	HSPG2 COL6A1 LAMA1 ITGB1	1.03e-05	29	164	4	22613833
Pubmed	Integrin alpha6beta1-laminin interactions regulate early myotome formation in the mouse embryo.	HSPG2 LAMA1 ITGB1	1.21e-05	10	164	3	16554364
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	KIF23 ABCB7 MAN2A1 MARS1 DUSP3 GEMIN5 ITGB1 HNRNPU S100A11 IGF2R CNPY3 SDF4 TMED2 CTPS1 CTSD PLOD2 TOP3B CTSZ PCYOX1	1.28e-05	1297	164	19	33545068
Pubmed	TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.	HSPG2 COL6A1 ITGB1 IGF2R CTSD PLOD2 PCYOX1	1.36e-05	164	164	7	32409323
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	HSPG2 COL6A1 ABCB7 MAN2A2 MAN2A1 PFKL ITGB1 AK3 HNRNPU MSN IGF2R SBF1 AKR7L AKR7A3 OSBPL11 TMED2 CTPS1 PLOD2 CTSZ PCYOX1	1.79e-05	1451	164	20	30550785
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	MARS1 ZNF318 PFKL LCP1 HNRNPU MSN YEATS2 S100A11 MSH6 IGF2BP1 TNRC18 TIAL1 TUBGCP3 RBM5 CTPS1 MBD2 PRRC2A	1.98e-05	1103	164	17	34189442
Pubmed	Synergistic activities of alpha3 and alpha6 integrins are required during apical ectodermal ridge formation and organogenesis in the mouse.	HSPG2 LAMA1 ITGB1	2.20e-05	12	164	3	10433923
Pubmed	ARPP-16/ARPP-19: a highly conserved family of cAMP-regulated phosphoproteins.	ARPP19 ENSA	2.21e-05	2	164	2	11279279
Pubmed	Molecular cloning and expression of cDNAs encoding human alpha-mannosidase II and a previously unrecognized alpha-mannosidase IIx isozyme.	MAN2A2 MAN2A1	2.21e-05	2	164	2	8524845
Pubmed	Lifecycle of Weibel-Palade bodies.	VWF RAB27A	2.21e-05	2	164	2	28004844
Pubmed	Pericellular colocalisation and interactive properties of type VI collagen and perlecan in the intervertebral disc.	HSPG2 COL6A1	2.21e-05	2	164	2	27377666
Pubmed	Rare loss of function mutations in N-methyl-D-aspartate glutamate receptors and their contributions to schizophrenia susceptibility.	GRIN2C GRIN2D	2.21e-05	2	164	2	29317596
Pubmed	Initiation of the TORC1-regulated G0 program requires Igo1/2, which license specific mRNAs to evade degradation via the 5'-3' mRNA decay pathway.	ARPP19 ENSA	2.21e-05	2	164	2	20471941
Pubmed	NMDA GluN2C/2D receptors contribute to synaptic regulation and plasticity in the anterior cingulate cortex of adult mice.	GRIN2C GRIN2D	2.21e-05	2	164	2	33766086
Pubmed	Defective acidification of intracellular organelles results in aberrant secretion of cathepsin D in cancer cells.	IGF2R CTSD	2.21e-05	2	164	2	15258139
Pubmed	Essential and mutually compensatory roles of {alpha}-mannosidase II and {alpha}-mannosidase IIx in N-glycan processing in vivo in mice.	MAN2A2 MAN2A1	2.21e-05	2	164	2	16754854
Pubmed	In the Telencephalon, GluN2C NMDA Receptor Subunit mRNA is Predominately Expressed in Glial Cells and GluN2D mRNA in Interneurons.	GRIN2C GRIN2D	2.21e-05	2	164	2	29651654
Pubmed	Differential effect of NMDA receptor GluN2C and GluN2D subunit ablation on behavior and channel blocker-induced schizophrenia phenotypes.	GRIN2C GRIN2D	2.21e-05	2	164	2	31110197
Pubmed	Alpha endosulfine is a novel molecule, structurally related to a family of phosphoproteins.	ARPP19 ENSA	2.21e-05	2	164	2	8687439
Pubmed	Enhanced function of NR2C/2D-containing NMDA receptor in the nucleus accumbens contributes to peripheral nerve injury-induced neuropathic pain and depression in mice.	GRIN2C GRIN2D	2.21e-05	2	164	2	35057644
Pubmed	NMDA receptors containing GluN2C and GluN2D subunits have opposing roles in modulating neuronal oscillations; potential mechanism for bidirectional feedback.	GRIN2C GRIN2D	2.21e-05	2	164	2	31786200
Pubmed	Cytohesin-1, a cytosolic guanine nucleotide-exchange protein for ADP-ribosylation factor.	CYTH2 CYTH1	2.21e-05	2	164	2	9050849
Pubmed	N-Glycan structure analysis using lectins and an alpha-mannosidase activity assay.	MAN2A2 MAN2A1	2.21e-05	2	164	2	17113875
Pubmed	Germ cell survival through carbohydrate-mediated interaction with Sertoli cells.	MAN2A2 MAN2A1	2.21e-05	2	164	2	11778047
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CDK17 ABCB7 IFT81 RALGAPB FNDC3A ITGB1 FAM83B DIP2A IGF2R SBF1 TUBGCP3 CCDC138 SDF4 TMED2 PDCL ADGRL2 PLOD2 TOP3B COA7 ENSA	2.53e-05	1487	164	20	33957083
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	MARS1 IFT81 USP9Y NEB LCP1 DIP2A VPS13D TIAL1 CTPS1 TOP3B COA7	2.62e-05	497	164	11	36774506
Pubmed	The first draft of the endostatin interaction network.	COL6A1 LAMA1 ITGB1	3.61e-05	14	164	3	19542224
Pubmed	Sonic hedgehog-dependent synthesis of laminin alpha1 controls basement membrane assembly in the myotome.	HSPG2 LAMA1 ITGB1	3.61e-05	14	164	3	19783738
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	HSPG2 COL6A1 COL8A2 VWF ANXA4 CTSD	4.56e-05	135	164	6	28675934
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	KIF23 ARPP19 RGPD8 FNDC3A ITGB1 CEP350 YEATS2 IGF2R ZFP1 RBM5 SDF4 PRR14L CTPS1	4.85e-05	733	164	13	34672954
Pubmed	Patterns of laminins and integrins in the embryonic ventricular zone of the CNS.	HSPG2 LAMA1 ITGB1	5.51e-05	16	164	3	17948866
Pubmed	Breakdown of the reciprocal stabilization of QBRICK/Frem1, Fras1, and Frem2 at the basement membrane provokes Fraser syndrome-like defects.	HSPG2 COL6A1 LAMA1	5.51e-05	16	164	3	16880404
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	KIF23 RGPD8 PDE1B TBL1Y CYTH2 CYTH1 SENP3 ZNF318 GRIN2D HNRNPU MSN IGF2R SBF1 TOP3B PRRC2A	5.54e-05	963	164	15	28671696
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	SOX11 ANXA4 FNDC3A FSCB TIAM2 MSN SORCS1 PTPRF TIAL1 CCDC138 ASTN1 CTPS1 CTSD	6.45e-05	754	164	13	35906200
Pubmed	Inflammatory Bowel Disease Susceptibility Gene C1ORF106 Regulates Intestinal Epithelial Permeability.	CYTH2 CYTH1	6.61e-05	3	164	2	31022698
Pubmed	Genetic variants of Y chromosome are associated with a protective lipid profile in black men.	TBL1Y USP9Y	6.61e-05	3	164	2	18511697
Pubmed	Auditory pathway and auditory brainstem response in mice lacking NMDA receptor epsilon 1 and epsilon 4 subunits.	GRIN2C GRIN2D	6.61e-05	3	164	2	9718984
Pubmed	[Purification of recombinant AKR7A5 protein and measurement of substrate specificity of AKR7A5 towards naphthoquinone and its derivatives].	AKR7L AKR7A3	6.61e-05	3	164	2	22863590
Pubmed	TIA nuclear proteins regulate the alternate splicing of lysyl hydroxylase 2.	TIAL1 PLOD2	6.61e-05	3	164	2	19110540
Pubmed	The platelet glycoprotein Ib-von Willebrand factor interaction activates the collagen receptor alpha2beta1 to bind collagen: activation-dependent conformational change of the alpha2-I domain.	VWF ITGB1	6.61e-05	3	164	2	15514009
Pubmed	The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.	HSPG2 ITGB1	6.61e-05	3	164	2	9431988
Pubmed	Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin.	HSPG2 ITGB1	6.61e-05	3	164	2	15240572
Pubmed	Structural basis and mechanism of autoregulation in 3-phosphoinositide-dependent Grp1 family Arf GTPase exchange factors.	CYTH2 CYTH1	6.61e-05	3	164	2	18042453
Pubmed	Laminin-derived peptide AG73 regulates migration, invasion, and protease activity of human oral squamous cell carcinoma cells through syndecan-1 and beta1 integrin.	LAMA1 ITGB1	6.61e-05	3	164	2	20237901
Pubmed	Characterisation of a novel mouse liver aldo-keto reductase AKR7A5.	AKR7L AKR7A3	6.61e-05	3	164	2	12123834
Pubmed	The perlecan fragment LG3 regulates homing of mesenchymal stem cells and neointima formation during vascular rejection.	HSPG2 ITGB1	6.61e-05	3	164	2	25808553
Pubmed	Human alpha-endosulfine, a possible regulator of sulfonylurea-sensitive KATP channel: molecular cloning, expression and biological properties.	ARPP19 ENSA	6.61e-05	3	164	2	9653196
Pubmed	Aldo-keto reductase 7A5 (AKR7A5) attenuates oxidative stress and reactive aldehyde toxicity in V79-4 cells.	AKR7L AKR7A3	6.61e-05	3	164	2	24590062
Pubmed	Characterization of L-plastin interaction with beta integrin and its regulation by micro-calpain.	LCP1 ITGB1	6.61e-05	3	164	2	20183869
Pubmed	PLOD2-driven IL-6/STAT3 signaling promotes the invasion and metastasis of oral squamous cell carcinoma via activation of integrin β1.	ITGB1 PLOD2	6.61e-05	3	164	2	33887877
Pubmed	A single C-terminal peptide segment mediates both membrane association and localization of lysyl hydroxylase in the endoplasmic reticulum.	CTSD PLOD2	6.61e-05	3	164	2	10748089
Pubmed	α1- and α5-containing laminins regulate the development of bile ducts via β1 integrin signals.	LAMA1 ITGB1	6.61e-05	3	164	2	22761447
Pubmed	Reciprocal expressions between α-dystroglycan and integrin β1, perlecan receptors, in the murine enamel organ development.	HSPG2 ITGB1	6.61e-05	3	164	2	23722005
Pubmed	Alpha2(VIII) collagen substrata enhance endothelial cell retention under acute shear stress flow via an alpha2beta1 integrin-dependent mechanism: an in vitro and in vivo study.	COL8A2 ITGB1	6.61e-05	3	164	2	16908762
Pubmed	Cocaine preference and neuroadaptations are maintained by astrocytic NMDA receptors in the nucleus accumbens.	GRIN2C GRIN2D	6.61e-05	3	164	2	35867797
Pubmed	Essential Role of the a3 Isoform of V-ATPase in Secretory Lysosome Trafficking via Rab7 Recruitment.	TCIRG1 RAB27A	6.61e-05	3	164	2	29712939
Pubmed	Integrin α6β1 Expressed in ESCs Instructs the Differentiation to Endothelial Cells.	LAMA1 ITGB1	6.61e-05	3	164	2	25693840
Pubmed	Facilitation of GluN2C-containing NMDA receptors in the external globus pallidus increases firing of fast spiking neurons and improves motor function in a hemiparkinsonian mouse model.	GRIN2C GRIN2D	6.61e-05	3	164	2	33421565
Pubmed	The N termini of a-subunit isoforms are involved in signaling between vacuolar H+-ATPase (V-ATPase) and cytohesin-2.	CYTH2 TCIRG1	6.61e-05	3	164	2	23288846
Pubmed	Novel homodimeric and heterodimeric rat gamma-hydroxybutyrate synthases that associate with the Golgi apparatus define a distinct subclass of aldo-keto reductase 7 family proteins.	AKR7L AKR7A3	6.61e-05	3	164	2	12071861
Pubmed	Mouse aldo-keto reductase AKR7A5 protects V79 cells against 4-hydroxynonenal-induced apoptosis.	AKR7L AKR7A3	6.61e-05	3	164	2	16919859
Pubmed	AKR7A5 knockout promote acute liver injury by inducing inflammatory response, oxidative stress and apoptosis in mice.	AKR7L AKR7A3	6.61e-05	3	164	2	39365156
Pubmed	Alpha L beta 2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1, a cytoplasmic regulatory molecule.	CYTH2 CYTH1	6.61e-05	3	164	2	8706128
Pubmed	Phosphoinositide specificity determines which cytohesins regulate β1 integrin recycling.	CYTH2 ITGB1	6.61e-05	3	164	2	22454518
Pubmed	Localization of the human NMDAR2D receptor subunit gene (GRIN2D) to 19q13.1-qter, the NMDAR2A subunit gene to 16p13.2 (GRIN2A), and the NMDAR2C subunit gene (GRIN2C) to 17q24-q25 using somatic cell hybrid and radiation hybrid mapping panels.	GRIN2C GRIN2D	6.61e-05	3	164	2	9480759
Pubmed	Differential expression profiles between α-dystroglycan and integrin β1 in ameloblastoma: two possible perlecan signalling pathways for cellular growth and differentiation.	HSPG2 ITGB1	6.61e-05	3	164	2	21255062
Pubmed	Modulation of cathepsin D routing by IGF-II involves IGF-II binding to IGF-II/M6P receptor in MCF-7 breast cancer cells.	IGF2R CTSD	6.61e-05	3	164	2	15518240
Pubmed	Distinct acidic clusters and hydrophobic residues in the alternative splice domains X1 and X2 of alpha7 integrins define specificity for laminin isoforms.	LAMA1 ITGB1	6.61e-05	3	164	2	17618648
Pubmed	Complex regulation of multiple cytohesin-like genes in murine tissues and cells.	CYTH2 CYTH1	6.61e-05	3	164	2	9744817
Pubmed	Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin.	HNRNPU IGF2R AKR7L AKR7A3 CTPS1 CTSD	7.90e-05	149	164	6	26370502
Pubmed	The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.	HSPG2 ABCB7 MARS1 PFKL MSN IGF2BP1 TUBGCP3 CTPS1	9.10e-05	298	164	8	30737378
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	HSPG2 COL6A1 LAMA1 ITGB1	9.27e-05	50	164	4	23658023
Pubmed	Proteomics characterization of extracellular space components in the human aorta.	HSPG2 COL6A1 COL8A2 CTSD CTSZ	1.21e-04	101	164	5	20551380
Pubmed	Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity.	HSPG2 ITGB1	1.32e-04	4	164	2	19789387
Pubmed	Aflatoxin B1 aldehyde reductase (AFAR) genes cluster at 1p35-1p36.1 in a region frequently altered in human tumour cells.	AKR7L AKR7A3	1.32e-04	4	164	2	12879023
Pubmed	Glycosylation catalyzed by lysyl hydroxylase 3 is essential for basement membranes.	LAMA1 PLOD2	1.32e-04	4	164	2	16467571
Pubmed	The N-terminal coiled coil domain of the cytohesin/ARNO family of guanine nucleotide exchange factors interacts with the scaffolding protein CASP.	CYTH2 CYTH1	1.32e-04	4	164	2	12052827
Pubmed	Attenuation of cell adhesion in lymphocytes is regulated by CYTIP, a protein which mediates signal complex sequestration.	CYTH2 CYTH1	1.32e-04	4	164	2	12606567
Pubmed	Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation.	LAMA1 ITGB1	1.32e-04	4	164	2	12670870
Pubmed	Integrin α6β1 is the main receptor for vascular laminins and plays a role in platelet adhesion, activation, and arterial thrombosis.	VWF ITGB1	1.32e-04	4	164	2	23797810
Pubmed	Early-Onset Alzheimer Disease and Candidate Risk Genes Involved in Endolysosomal Transport.	RIN3 TCIRG1	1.32e-04	4	164	2	28738127
Pubmed	Specific functional interaction of human cytohesin-1 and ADP-ribosylation factor domain protein (ARD1).	CYTH2 CYTH1	1.32e-04	4	164	2	10748148
Pubmed	Structural insights into assembly and function of GluN1-2C, GluN1-2A-2C, and GluN1-2D NMDARs.	GRIN2C GRIN2D	1.32e-04	4	164	2	36309015
Pubmed	The histone acetyltransferase PCAF associates with actin and hnRNP U for RNA polymerase II transcription.	HNRNPU KAT2B	1.32e-04	4	164	2	18710935
Pubmed	Similarities in function and gene structure of cytohesin-4 and cytohesin-1, guanine nucleotide-exchange proteins for ADP-ribosylation factors.	CYTH2 CYTH1	1.32e-04	4	164	2	10652308
Pubmed	Exome sequencing revealed DNA variants in NCOR1, IGF2BP1, SGLT2 and NEK11 as potential novel causes of ketotic hypoglycemia in children.	SLC5A2 IGF2BP1	1.32e-04	4	164	2	32034166
GeneFamily	C2 domain containing\|Calpains	CAPN9 CAPN14 CAPN11	1.25e-04	15	121	3	975
GeneFamily	Mannosidases alpha class 2	MAN2A2 MAN2A1	4.38e-04	5	121	2	1194
GeneFamily	EF-hand domain containing	CAPN9 CAPN14 LCP1 CAPN11 S100A11 RPTN SDF4	6.83e-04	219	121	7	863
GeneFamily	Glutamate ionotropic receptor NMDA type subunits	GRIN2C GRIN2D	9.13e-04	7	121	2	1201
Coexpression	VERHAAK_GLIOBLASTOMA_MESENCHYMAL	COL8A2 MAN2A1 ANXA4 TCIRG1 LCP1 S100A11 RABGAP1L FMNL1 RAB27A CTSZ	1.08e-06	216	163	10	M2122
Coexpression	NUYTTEN_NIPP1_TARGETS_UP	CDK17 LAMA1 KATNAL1 GK5 C3orf33 YEATS2 SPATA17 TRAM1L1 TTC7B PTPRF CYP2R1 PTPRR RABGAP1L CCDC138 L3HYPDH PLOD2 ARAP2	6.46e-06	768	163	17	M6444
Coexpression	NABA_MATRISOME_BLEO_FIBROTIC_LUNG	HSPG2 COL6A1 S100A11 CTSD	6.46e-06	20	163	4	MM17053
Coexpression	YAMAZAKI_TCEB3_TARGETS_UP	HSPG2 PDE1B LAMA1 FNDC3A ITGB1 TMED2 PLOD2 CTSZ	9.87e-06	166	163	8	M1542
Coexpression	YAMAZAKI_TCEB3_TARGETS_UP	HSPG2 PDE1B LAMA1 FNDC3A ITGB1 TMED2 PLOD2 CTSZ	1.71e-05	179	163	8	MM660
Coexpression	NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS	COL6A1 ANXA4 LAMA1 S100A11	3.03e-05	29	163	4	MM17055
Coexpression	MULLIGHAN_MLL_SIGNATURE_1_UP	CLTCL1 ZNF318 LCP1 HNRNPU IGF2R AKR7A3 CNPY3 PCNX1 SDF4 IL17RA RAB27A	3.11e-05	385	163	11	M17856
Coexpression	GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN	ANXA4 TCIRG1 KATNAL1 ITGB1 KAT2B RABGAP1L SLAMF7 RAB27A	3.78e-05	200	163	8	M4659
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	CDK17 ARPP19 MAN2A2 PHF20 CYTH1 RALGAPB LCP1 SLC7A6 HNRNPU MSN CEP350 DIP2A KAT2B TIAL1 RABGAP1L CD101 PCNX1 IL17RA SLAMF7 MBD2 FMNL1 RAB27A ARAP2	5.29e-05	1492	163	23	M40023
Coexpression	NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR	HSPG2 LAMA1 S100A11 CTSD	6.49e-05	35	163	4	MM17054
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CDK17 USP9Y GK5 HNRNPU SLFN12L DIP2A DTHD1 ARAP2 RGPD5 PARP15	3.71e-09	199	164	10	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Control-NK\|Control / Disease condition and Cell class	RIN3 LCP1 GK5 MSN DIP2A IGF2R SLAMF7 DTHD1 CTSD	5.66e-08	199	164	9	f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	USP9Y LCP1 MSN DIP2A KAT2B IGF2R SLAMF7 DTHD1 ARAP2	5.91e-08	200	164	9	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RIN3 LCP1 DNAI3 SLFN12L CD101 PCNX1 ARAP2 PARP15	2.23e-07	169	164	8	8caf7996796a2e2716e3855de855c903d6126bf2
ToppCell	390C-Lymphocytic-ILC-ILC-1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	FAM185A MAN2A2 PHF20 RALGAPB RDH14 SLC7A6 METTL25 TOP3B	3.45e-07	179	164	8	3edcd1356e49b1f5514c585861999e079ca5e579
ToppCell	390C-Lymphocytic-ILC-ILC-1\|390C / Donor, Lineage, Cell class and subclass (all cells)	FAM185A MAN2A2 PHF20 RDH14 SLC7A6 HELQ METTL25 TOP3B	3.45e-07	179	164	8	e7045e27f0eb88f552b31c04b56d78e5ccd7a36c
ToppCell	normal-na-Lymphocytic_NK-NK_dim-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	LCP1 GK5 SLFN12L DIP2A SLAMF7 DTHD1 CTSD ARAP2	4.44e-07	185	164	8	b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c
ToppCell	COVID-19-T_cells-NK_cells\|COVID-19 / group, cell type (main and fine annotations)	GK5 SLFN12L DIP2A KAT2B ST8SIA6 RABGAP1L DTHD1 ARAP2	5.22e-07	189	164	8	b699152dfbb8cd8ed724e1e5a51838f29b681b62
ToppCell	COVID-19-lung-NK/NKT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RIN3 LCP1 SLFN12L SLAMF7 DTHD1 FMNL1 ARAP2 PARP15	6.11e-07	193	164	8	c24b44fcc92fff42ebba6f1aff91c7aaea179e56
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD16\|lymph-node_spleen / Manually curated celltypes from each tissue	RIN3 GK5 DIP2A IGF2R ST8SIA6 SLAMF7 DTHD1 CTSD	6.87e-07	196	164	8	f7e5a7fad4547e8ab9ab8b140239281832fb4260
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP9Y GK5 SLFN12L DIP2A DTHD1 ARAP2 RGPD5 PARP15	7.14e-07	197	164	8	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	healthy_donor-Lymphocytic-ILC-NK_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	LCP1 GK5 MSN SLFN12L DIP2A IGF2R SLAMF7 DTHD1	7.41e-07	198	164	8	d7053a898e04478c577381085f615edaad3cdc5b
ToppCell	healthy_donor-Lymphocytic-ILC\|healthy_donor / Disease condition, Lineage, Cell class and subclass	LCP1 GK5 MSN SLFN12L DIP2A IGF2R SLAMF7 DTHD1	7.41e-07	198	164	8	aa33be29e26f1b8facfc894413099083ae3bbb1b
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RIN3 LCP1 SLFN12L DIP2A ST8SIA6 SLAMF7 DTHD1 FMNL1	8.00e-07	200	164	8	7d90fcb5dfc4c9d562c93b0f9293ed12b5f4f404
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RIN3 LCP1 SLFN12L DIP2A ST8SIA6 SLAMF7 DTHD1 FMNL1	8.00e-07	200	164	8	d2422aaf807010194994db97142b9fd2e807312d
ToppCell	COVID-19_Severe-NK_activated\|COVID-19_Severe / Disease condition and Cell class	TCIRG1 LCP1 GK5 MSN S100A11 DIP2A SLAMF7 DTHD1	8.00e-07	200	164	8	f1f6c7f7f75f891c9ccf6bf58f4d65b9cf10bbd8
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RIN3 LCP1 SLFN12L DIP2A ST8SIA6 SLAMF7 DTHD1 FMNL1	8.00e-07	200	164	8	1d2ee63010b7b8b38bea7d3b30eebfbcdd18b967
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCDHB14 SEZ6L2 TIAM2 TNRC18 GALNT17 CANT1 MANSC4	1.94e-06	157	164	7	1f21d78a467fe22c5ab75d0917b840c1ac93f32c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CDHR1 LCP1 SLFN12L SLAMF7 DTHD1 FMNL1 PARP15	3.04e-06	168	164	7	318fa1bd5a9d6ae95042517ef30515b6416b61e4
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CDHR1 LCP1 SLFN12L SLAMF7 DTHD1 FMNL1 PARP15	3.04e-06	168	164	7	75b3998aff704a77895ee3723813d8a3819b7cec
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	OTOA CAPN14 ANXA4 S100A11 MBD2 CTSD CTSZ	5.53e-06	184	164	7	65b00145cb7da7d64eb6765569573c1a902a1036
ToppCell	COVID-19_Severe-gd_T\|COVID-19_Severe / Disease condition and Cell class	CDHR1 LCP1 MSN DIP2A IGF2R PCNX1 SLAMF7	5.53e-06	184	164	7	791f1bcb954aadc63d4117c400537d036f68734d
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ARPP19 TIAM2 ADORA1 IL17RA ADGRL2 FMNL1 ARAP2	5.93e-06	186	164	7	56c139e679d640ea901ead657a8e8887e0fca098
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	CDK17 HSPG2 VWF PRAG1 ST8SIA6 PTPRR ADGRF5	7.06e-06	191	164	7	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	RIN3 LCP1 DIP2A IGF2R SLAMF7 DTHD1 CTSD	7.55e-06	193	164	7	b53ffef20f918b7d1e9d3924562691d13245e2dd
ToppCell	3'_v3-blood-Lymphocytic_NK\|blood / Manually curated celltypes from each tissue	RIN3 PHF20 GK5 DIP2A SLAMF7 DTHD1 FMNL1	8.08e-06	195	164	7	731a454e45c7b610e0140312bcabaea711dcc766
ToppCell	CV-Moderate-6\|Moderate / Virus stimulation, Condition and Cluster	PHF20 ITGB1 CEP350 KAT2B IGF2R SLAMF7 FMNL1	8.08e-06	195	164	7	2b8a72d7e755b9655c7a496000d10ff06e50862b
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	PHF20 ITGB1 CEP350 KAT2B IGF2R SLAMF7 FMNL1	8.35e-06	196	164	7	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	background-NK_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	CDHR1 LCP1 MSN SLFN12L ST8SIA6 SLAMF7 DTHD1	8.63e-06	197	164	7	e8e1d3e557fe821efe81012e759e35e4ae33ce86
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	LCP1 ITGB1 MSN DIP2A SLAMF7 DTHD1 CTSD	8.92e-06	198	164	7	faeef749a4b4bdc7f3edb6923e0e248e8b92c9d0
ToppCell	COVID_non-vent-Lymphocytic-ILC\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	GK5 SLFN12L DIP2A IGF2R SLAMF7 DTHD1 ARAP2	9.22e-06	199	164	7	df4f7d5be099e3e6054f3b812ccf70251664e4c0
ToppCell	COVID-19_Moderate-NK\|World / disease group, cell group and cell class	GK5 SLFN12L IGF2R SLAMF7 DTHD1 ARAP2 PARP15	9.22e-06	199	164	7	c41b67b760831c7d5e19fabcc932a056dc560f93
ToppCell	COVID-19_Moderate-NK\|COVID-19_Moderate / disease group, cell group and cell class	GK5 SLFN12L IGF2R ST8SIA6 DTHD1 CTSD ARAP2	9.22e-06	199	164	7	e0e83ba511957be9ad3413460dcb6b7d7b65dd18
ToppCell	COVID_non-vent-Lymphocytic-ILC-NK_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	GK5 SLFN12L DIP2A IGF2R SLAMF7 DTHD1 ARAP2	9.22e-06	199	164	7	ed35d747f11f6ea6a5cb7061057f0a98d9e0db99
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDE1B LCP1 PRAG1 OSBPL11 MBD2 CTSD CTSZ	9.22e-06	199	164	7	fde8e3ba19d19069a4d3b8db55bfe6220cf634d5
ToppCell	Kidney-Keratinocytes\|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients.	CDHR1 USP9Y SORCS1 CRYBB2 ST8SIA6 MBD2 COA7	9.53e-06	200	164	7	41d83faa9f45ee7ea2ab19be8ecc6d2c5ac7fe5d
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RIN3 LCP1 SLFN12L ST8SIA6 SLAMF7 DTHD1 PARP15	9.53e-06	200	164	7	7eed3d932018d6a87ce37d013883b371db55caeb
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Mesenchymal-BMP_responsible_cell\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	COL8A2 RIN3 ANXA4 LCP1 S100A11 IL17RA CTSD	9.53e-06	200	164	7	cd0d69f973ca3204b500d12031b403a1f4593431
ToppCell	mild-NK\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	GK5 SLFN12L IGF2R SLAMF7 DTHD1 ARAP2 PARP15	9.53e-06	200	164	7	a11fb1d7e124c352eb73fea0e0ec0fed577c97f7
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RIN3 LCP1 SLFN12L ST8SIA6 SLAMF7 DTHD1 PARP15	9.53e-06	200	164	7	56d738ff019682af7f1f8cbe7b262a75dc8596d5
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RIN3 LCP1 SLFN12L ST8SIA6 SLAMF7 DTHD1 PARP15	9.53e-06	200	164	7	0f8e2fed93cc103b20a825d8d3e83787c5c015cc
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL6A1 IFT81 DNAI3 L3HYPDH PRR14L PARP15	1.98e-05	150	164	6	53de595376a9fc92491dfd58ff25938b0bf79903
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL6A1 IFT81 DNAI3 L3HYPDH PRR14L PARP15	1.98e-05	150	164	6	e4b40b3243ed26d0c46bf196ac06e148834e7ed2
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HSPG2 VWF ST8SIA6 PTPRR PLA2G5 RGPD5	2.57e-05	157	164	6	275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIN3 CDHR1 SLFN12L SLAMF7 DTHD1 PARP15	3.28e-05	164	164	6	649e42d9cfdec2f7771d1e938b516e46e7d07078
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIN3 CDHR1 SLFN12L SLAMF7 DTHD1 PARP15	3.28e-05	164	164	6	ba85f7b21ae34e285d286ada24715885ca6329f7
ToppCell	facs-BAT-Fat-18m-Myeloid-granulocyte\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LCP1 S100A11 CD101 IL17RA CTSD RAB27A	3.88e-05	169	164	6	d3e6c75e5eda133fb6535cfe6c6a1026641f26ac
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	OTOA LCP1 IGF2R SLAMF7 CTSD CTSZ	4.14e-05	171	164	6	b520d4d5620cac08315e4cbb7e796c5e9e233060
ToppCell	mild-Others-CD34+_GATA2+_cells\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HSPG2 IFT81 SEZ6L2 SLC9C1 ST8SIA6 PLOD2	4.28e-05	172	164	6	379f6f271e653d5e404851e51a189bd582bb0f43
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	GK5 ITGB1 SLFN12L DIP2A KAT2B ST8SIA6	4.42e-05	173	164	6	36a471576a9d2325066bb14c2f2cd89c67b92915
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LCP1 SLFN12L SLAMF7 DTHD1 FMNL1 PARP15	4.56e-05	174	164	6	47e308a777c927ae69ed344cb3dd8561bf2c48a5
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LCP1 SLFN12L SLAMF7 DTHD1 FMNL1 PARP15	4.56e-05	174	164	6	a92c745d20633909db0f08effa13fc738fda79a6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANXA4 GALNT17 ST8SIA6 SHOC1 ADGRF5 ST8SIA5	4.71e-05	175	164	6	1d8da48236549c01381f777ce5b2937f9f86acc2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANXA4 GALNT17 ST8SIA6 SHOC1 ADGRF5 ST8SIA5	4.86e-05	176	164	6	c2c4306476989bc2fb30dab00250ef7915842f13
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCIRG1 LCP1 IL17RA CTSD FMNL1 CTSZ	5.02e-05	177	164	6	1e7b4c0e41649d57a2c219a3b7e693538b8b34e4
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TCIRG1 S100A11 MBD2 CTSD TOP3B CTSZ	5.18e-05	178	164	6	30d2b54462fd16222ad2e3806be6143e834b29e0
ToppCell	LA-04._Ventricular_Cardiomyocyte_I\|LA / Chamber and Cluster_Paper	ARPP19 KAT2B ADGRL2 DTHD1 PIWIL3	5.44e-05	110	164	5	34dcd1e1e16e8b6088ff9a7a40532e8bd000c121
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PARP3 LCP1 ZFP1 DTHD1 CTSD PIWIL3	5.51e-05	180	164	6	557453b74d4a9cc95ed1c7b9a9a58e45eb02ed6a
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_2\|368C / Donor, Lineage, Cell class and subclass (all cells)	RDH14 LCAT YEATS2 SLFN12L CACNA2D4 CD101	5.51e-05	180	164	6	551b8de8d933d11bcd3897aeb2fd033355f958e2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LCP1 SLFN12L SLAMF7 DTHD1 FMNL1 PARP15	5.51e-05	180	164	6	bb2dbf7ed03d5ac765635b7afe738efa822841d0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LCP1 SLFN12L SLAMF7 DTHD1 FMNL1 PARP15	5.51e-05	180	164	6	c62417f205bcbf3b212ae177f63562ec6467c855
ToppCell	PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	SOX11 DUSP3 PCDHB14 ADGRF5 TIMELESS ARAP2	5.68e-05	181	164	6	9cd5e5c285c2b628db9d59709af053defd7c0aff
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	USP9Y SLFN12L SLAMF7 DTHD1 RAB27A ARAP2	5.86e-05	182	164	6	f857b32de19240a8aca1685f7a78b4e53b04875c
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA SOX11 FAT3 LAMA1 NEB SORCS1	6.22e-05	184	164	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	HSPG2 VWF ST8SIA6 PTPRR ADGRF5 EGFLAM	6.22e-05	184	164	6	a809b0fa52df8a159f60f87eefcef61220af5e34
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA SOX11 FAT3 LAMA1 NEB SORCS1	6.22e-05	184	164	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA SOX11 FAT3 LAMA1 NEB SORCS1	6.22e-05	184	164	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Control-T_cells-CD8+_T_cells\|Control / group, cell type (main and fine annotations)	LCP1 SLFN12L DIP2A KAT2B RABGAP1L DTHD1	6.41e-05	185	164	6	02ab64c0166c0646d1d4c6ed110ef0b75a1096d0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LCP1 SLFN12L SLAMF7 DTHD1 FMNL1 PARP15	6.41e-05	185	164	6	45890fa81c65a48f4fdec164a4c8d0e2831243c0
ToppCell	10x5'v1-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	CDK17 CDHR1 SLFN12L SLAMF7 DTHD1 ARAP2	6.41e-05	185	164	6	593eceb3dfcc662c892a840ba29ab687c6886c01
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LCP1 SLFN12L SLAMF7 DTHD1 FMNL1 PARP15	6.41e-05	185	164	6	585bcfdff85bf43f5aa4cd1b39f7dcf1c78d7b02
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_1\|390C / Donor, Lineage, Cell class and subclass (all cells)	KATNAL1 SLC7A6 VPS13D AVIL OSBPL11 TOP3B	6.61e-05	186	164	6	064b6047215597465bb51a8a1547ef5a226552f9
ToppCell	Control-Lymphoid-CD8_T_cells\|Lymphoid / Condition, Lineage and Cell class	SLFN12L CD101 SLAMF7 DTHD1 RAB27A ARAP2	6.61e-05	186	164	6	a8a4c0f4058f5bbc435dd2dd41d55383173a1358
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RIN3 GK5 SORCS1 SLFN12L ST8SIA6 DTHD1	6.61e-05	186	164	6	c984e5729958237b101df96d1c89a236faacded6
ToppCell	3'_v3-blood-Lymphocytic_T_CD8-Trm/em_CD8\|blood / Manually curated celltypes from each tissue	USP9Y DNAI3 SLFN12L SLAMF7 DTHD1 ARAP2	7.01e-05	188	164	6	21730497f95dc271e4cdfaaf1da8b9ac6eec2ded
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANXA4 FAM83B GALNT17 ST8SIA6 ADGRF5 ST8SIA5	7.01e-05	188	164	6	e751cff2ac8fbc1487766c1871fcc5d1005286b0
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	KATNAL1 SLC7A6 VPS13D AVIL MBD2 TOP3B	7.01e-05	188	164	6	b1ec7c45aedcc3d22cac898c6a3679e7f8b44c77
ToppCell	Fetal_29-31_weeks-Immune-natural_killer_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RIN3 CDHR1 LCP1 SLFN12L SLAMF7 FMNL1	7.01e-05	188	164	6	1082861eb9e00409caa06d8b2a7b8e7f5fac94c9
ToppCell	Substantia_nigra-Endothelial\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	HSPG2 ANXA4 ITGB1 MSN S100A11 EGFLAM	7.22e-05	189	164	6	bef8234bd9c4d6e3cdef0791d8066b39ba56ebba
ToppCell	COPD-Lymphoid-NK\|World / Disease state, Lineage and Cell class	CDK17 SLFN12L DIP2A ST8SIA6 CTPS1 DTHD1	7.22e-05	189	164	6	c0ac160fa7e68b92414fb1600abcac8ad1a42232
ToppCell	Fetal_29-31_weeks-Immune-natural_killer_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RIN3 LCP1 SLFN12L SLAMF7 DTHD1 FMNL1	7.22e-05	189	164	6	c604da558c9f4055fb36218452463539f2a73223
ToppCell	COVID-19-Heart-EC_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HSPG2 VWF PRAG1 SLC9C1 ST8SIA6 ADGRF5	7.22e-05	189	164	6	fe49852ba15f948b384d6b4c258927c70b741357
ToppCell	Macrophages-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	PDE1B TCIRG1 LCP1 ADORA1 OSBPL11 FMNL1	7.22e-05	189	164	6	c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9
ToppCell	(2)_NK/T-(210)_NKT_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	ANXA4 GK5 MSN DIP2A IGF2BP1 IGF2R	7.22e-05	189	164	6	fa72e87e1e8cd7cbddae7b47e19cf90d181820a7
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	CDK17 HSPG2 VWF CYTH1 ST8SIA6 PLA2G5	7.22e-05	189	164	6	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	CDK17 HSPG2 VWF CYTH1 ST8SIA6 ADGRF5	7.22e-05	189	164	6	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	(2)_NK/T-(21)_NKT_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	ANXA4 GK5 MSN DIP2A IGF2BP1 IGF2R	7.22e-05	189	164	6	b37ad24898a14a4a3b2d6cea2637de2471f76e20
ToppCell	T_cells-GZMK+_CD8+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	LCP1 SLFN12L SLAMF7 DTHD1 RAB27A ARAP2	7.22e-05	189	164	6	e2ca075aedf7c370ab4ede6272254ffd06cbcdec
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARPP19 FAT3 PRAG1 SORCS1 ADGRL2 ARAP2	7.22e-05	189	164	6	c3df0e3c50af8f1cfb4d790e668bd7f42b276992
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LCP1 SLFN12L SLAMF7 DTHD1 FMNL1 PARP15	7.43e-05	190	164	6	4a75457652d85874d5c6a41648f8003572008b15
ToppCell	Control-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	RIN3 GK5 DIP2A IGF2R ST8SIA6 DTHD1	7.43e-05	190	164	6	1584c68b58c7f406d9b0e8451beea3e6f8980c56
ToppCell	COVID-19-kidney-NK\|kidney / Disease (COVID-19 only), tissue and cell type	LCP1 SLFN12L ST8SIA6 SLAMF7 DTHD1 FMNL1	7.43e-05	190	164	6	e3ca3c9fb9e27670a5dd128dd6564ff98a57159e
ToppCell	COVID-19-Heart-EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	CDK17 VWF ST8SIA6 PLA2G5 ADGRF5 EGFLAM	7.43e-05	190	164	6	a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LCP1 SLFN12L SLAMF7 DTHD1 FMNL1 PARP15	7.43e-05	190	164	6	cda6173634531240e0bab8766231a150ff8d0129
ToppCell	COVID-19-Heart-T_cell\|Heart / Disease (COVID-19 only), tissue and cell type	DPP6 LCP1 SLFN12L SLAMF7 DTHD1 ARAP2	7.43e-05	190	164	6	e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LCP1 SLFN12L PCNX1 DTHD1 FMNL1 PARP15	7.65e-05	191	164	6	1a2d5fec2bea96da2154b0aed252f1bb35102f6e
ToppCell	droplet-Lung-LUNG-1m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF LAMA1 PTPRR ADGRF5 ADGRL2 TSSK1B	7.65e-05	191	164	6	9fc674a58f20b47255e4457d5195c8cff17b0414
ToppCell	COVID-19-lung-CD8+_T_cells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LCP1 SLFN12L SLAMF7 DTHD1 FMNL1 ARAP2	7.65e-05	191	164	6	543f8ae07cc2e6950c888115a5ca9445e3c0f618
ToppCell	IPF-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	RIN3 GK5 DIP2A IGF2R ST8SIA6 DTHD1	7.65e-05	191	164	6	f2ddc0962007d7a4e78fbd916ebb62fc557d480a
ToppCell	droplet-Lung-LUNG-1m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF LAMA1 PTPRR ADGRF5 ADGRL2 TSSK1B	7.65e-05	191	164	6	c379a499dabf3c9ed80f47adbb2d949821c5b053
Computational	Neighborhood of STAT6	RIN3 TCIRG1 LCP1 MSN MBD2 FMNL1	5.28e-05	79	91	6	GNF2_STAT6
Computational	Neighborhood of ITGB2	RIN3 TCIRG1 MSN FMNL1 RAB27A	1.15e-04	57	91	5	GNF2_ITGB2
Drug	Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A	MAN2A1 SEZ6L2 ITGB1 IGF2R PTPRF IL17RA PLOD2 SLC6A14 PCYOX1	2.37e-06	161	162	9	3556_DN
Disease	level of carboxypeptidase A1 in blood serum	CPA1 ZFP1	8.84e-05	3	161	2	OBA_2041112
Disease	Liver Cirrhosis, Experimental	COL6A1 VWF ANXA4 LCP1 ITGB1 MSN S100A11 IGF2R TIAL1 RABGAP1L L3HYPDH PLOD2 FMNL1 CTSZ	9.39e-05	774	161	14	C0023893
Disease	Ventricular Dysfunction	ADORA1 IGF2R	8.11e-04	8	161	2	C0242973
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	CAPN9 CAPN11 SLC6A14	9.97e-04	36	161	3	DOID:11723 (implicated_via_orthology)
Disease	Herpes Zoster, response to tofacitinib	VWF IGF2BP1	1.88e-03	12	161	2	EFO_0006510, EFO_0600024
Disease	myeloid white cell count	RIN3 CYP8B1 IFT81 AK3 SLFN12L DIP2A DHRS12 GALNT17 RABGAP1L ADGRF5 IL17RA DTHD1 MBD2	1.95e-03	937	161	13	EFO_0007988
Disease	amyotrophic lateral sclerosis, age at onset	PTPRF ARAP2	2.97e-03	15	161	2	EFO_0004847, MONDO_0004976
Disease	hair morphology measurement	PRAG1 S100A11 OSBPL11	3.23e-03	54	161	3	EFO_0007821
Disease	phosphatidylcholine 38:3 measurement	DPP6 IGF2R	3.38e-03	16	161	2	EFO_0010385
Disease	factor VIII measurement, coronary artery disease	VWF LCP1 IGF2R PRRC2A	3.47e-03	113	161	4	EFO_0001645, EFO_0004630
Disease	microglial activation measurement	FAT3 ARMC9 GALNT17	4.14e-03	59	161	3	EFO_0010940
Disease	mean reticulocyte volume	KIF23 ABCB7 ZNF318 NEB LCP1 AK3 CEP350 DIP2A KAT2B PTPRF MBD2	4.55e-03	799	161	11	EFO_0010701
Disease	oleoylcarnitine measurement	RDH14 AKR7A3	4.76e-03	19	161	2	EFO_0021043
Disease	carotid artery disease (is_marker_for)	HSPG2 VWF	4.76e-03	19	161	2	DOID:3407 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
KRLQKGQKYFDSGDY	ENSA	56	O43768
IQTDKGSVYIYTFGK	CFAP43	361	Q8NDM7
SDTFRGYFKQGIIYK	AVIL	101	O75366
EVKYSTYGTGADLFL	CDHR1	506	Q96JP9
GLQYLLEKGDYKDSS	CRYBB2	161	P43320
LGYTVFYSEVGADKS	EGFLAM	66	Q63HQ2
KYSEFFTGSKLVDYA	SDF4	341	Q9BRK5
AGGLLTGKYKYEDKD	AKR7L	201	Q8NHP1
AGGLLTGKYKYEDKN	AKR7A3	201	O95154
YTSDGNTKYKLDIFL	CATSPERD	446	Q86XM0
VTSTYKDGKGARYNL	CTSZ	276	Q9UBR2
SASSGDPQKYYGKEL	ADORA1	216	P30542
ASLYGTKFNYGSIIK	CPA1	341	P15085
GVSAAIDYKSYGTEK	ADGRL2	966	O95490
LEGGFLSYYENDKST	ARAP2	926	Q8WZ64
YGKSLYSFIKGDTSG	ANXA4	291	P09525
YSFIKGDTSGDYRKV	ANXA4	296	P09525
EKAYAKLSGSYEALS	CAPN11	216	Q9UMQ6
KYGLNFYLIATEEGK	DNAI3	111	Q8IWG1
KRLQKGQKYFDSGDY	ARPP19	51	P56211
DKIYNLFNGYTSGKE	ASTN1	1166	O14525
ALLEKAYAKLSGSYE	CAPN14	176	A8MX76
AYAKLSGSYEDLQSG	CAPN14	181	A8MX76
GKTSVLYQYTDGKFN	RAB27A	21	P51159
DKVAAYGGKLRYTLS	HSPG2	1406	P98160
KYLQKTGSGLNSFYG	RGPD5	581	Q99666
KYLQKTGSGLNSFYG	RGPD8	581	O14715
NGKLSEGVTISYKSY	ITGB1	386	P05556
KGIYFASENSKSAGY	PARP3	411	Q9Y6F1
GYLDDSGYSIQDLKS	OTOA	946	Q7RTW8
GSEKYSDDTKYTDGL	IL17RA	351	Q96F46
KNAVSYGKGTYFAVD	PARP15	581	Q460N3
YGTTIKRDKSGAYLF	MAN2A1	796	Q16706
TKYVGYIKDYEGATL	KAT2B	631	Q92831
GSKGSYSAKAYESIR	FSCB	36	Q5H9T9
YTIFYQAEGGKGFSK	IL31RA	456	Q8NI17
KISYSGQFLVKSGYA	IGF2BP1	26	Q9NZI8
SYFKTYLETKGAALS	ARMC9	126	Q7Z3E5
GYLSSFLSLKYGLKV	METTL25	186	Q8N6Q8
FLSLKYGLKVYGIDS	METTL25	191	Q8N6Q8
DGLLKAKYLYTESSF	FAM185A	236	Q8N0U4
YYQKKGVLETFSGTE	AK3	186	Q9UIJ7
FSYLKKGYLTLSDSG	CANT1	126	Q8WVQ1
KLDSSYFKNRGIYTL	FAM83B	331	Q5T0W9
ATGYYTAGGKKTEEV	F13B	181	P05160
DYGSRNLTATKFKLY	PCNX1	1086	Q96RV3
GTSAAYYLRQKFGKD	PCYOX1	46	Q9UHG3
IGNFSTDIKDSKAYY	LCP1	286	P13796
SFLDALETGYGKYKN	PDE1B	206	Q01064
TEFLYNLYSSEGKGV	PFKL	636	P17858
EFSYGYSLKGIKTCN	HNRNPU	376	Q00839
YVPYFKDKGDSNSSA	FOXO6	121	A8MYZ6
LYKGEGLNKTAIGDY	CYTH1	101	Q15438
LGAQFLKYYSESTGQ	MANSC4	51	A6NHS7
YGVNYFSIKNKKGSE	MSN	201	P26038
QGKIDAAYFETSKYL	TUBGCP3	531	Q96CW5
TYIKLEKLGEGTYAT	CDK17	191	Q00537
EKLYFGLSYAKNGEL	PDPK2P	126	Q6A1A2
FGRYSDSLVQKGYKV	MSH6	466	P52701
YGLSGADSYKDAVRK	RBM5	791	P52756
YFKDTGGDGQESLYK	RABGAP1L	591	Q5R372
KVFAGYYTKGFALLN	PLOD2	636	O00469
ENRSYEGTLYKKGAF	SBF1	1761	O95248
YIRGYSGKEKAFIAT	PTPRR	451	Q15256
KVTGKNALTNYGFYG	PLA2G5	31	P39877
RKSGLSAGKSDVYYF	MBD2	166	Q9UBB5
AKDLDAGNYGKISYT	PCDHB14	266	Q9Y5E9
TDEKYYGSYSAKTNL	CD101	126	Q93033
EKKGISGYSYTQEEL	IFT81	451	Q8WYA0
YSGDKVGSSLKYSDE	CCDC138	56	Q96M89
SSYLNLEKLGEGSYA	CDK15	101	Q96Q40
LEKLGEGSYATVYKG	CDK15	106	Q96Q40
SVDAVKYFGKGTYTD	COL6A1	116	P12109
ADTFGGDLYNTVTKY	CACNA2D4	81	Q7Z3S7
YFGYGQKSFESKILE	CYP2R1	146	Q6VVX0
VSKKYFQYLGTYDTG	GALNT4	316	Q8N4A0
YGYEVLISSTGKDGK	FNDC3A	306	Q9Y2H6
DSKYYKGSLSYLNVT	CTSD	251	P07339
GYGILDQKASGVKYT	CNPY3	76	Q9BT09
YKKGYLDQASGGAVL	COL8A2	651	P25067
KYYATITGQFGLVKE	CCDC73	166	Q6ZRK6
YKGEGLNKTAIGDYL	CYTH2	101	Q99418
ASDKDKGENGYITYS	FAT3	496	Q8TDW7
SGFAYEYTLEINGKS	FAIM	71	Q9NVQ4
INIFTKSYQLYGKGF	CEP350	1066	Q5VT06
AKGLREYTKSGYESA	DHRS12	11	A0PJE2
LKKSLTATDFYNGYL	MTFMT	336	Q96DP5
EKYGYNSYLSEKISL	GALNT17	116	Q6IS24
FASSNGKDYGKDYTL	DTHD1	571	Q6ZMT9
TGSDFSLKKESYYEK	C3orf33	246	Q6P1S2
VYGTRTSKDKSGAYL	MAN2A2	801	P49641
AAYIQKLKSYVDTGG	FMNL1	81	O95466
NFYKDSGITYLGIKA	DUSP3	76	P51452
LYKLTKGSVYATDFS	GK5	201	Q6ZS86
GFGKTYSVEYLDSSK	LCAT	126	P04180
GTGTAYIEYKTSKEG	DIP2A	506	Q14689
EGRAKQLYSAGYKSL	HELQ	1021	Q8TDG4
LAYDEKGNKIYFLST	DPP6	491	P42658
AYAKLNGSYEALKGG	CAPN9	176	O14815
TFNKSDGSKITYIDY	PIWIL3	346	Q7Z3Z3
GKGSFRFSYSKNETY	C9	266	P02748
GYLSLFGYTKDKEQD	CYP8B1	181	Q9UNU6
KTDSSYFYRGDDQGK	PRR14L	376	Q5THK1
ETFTLGDKKNYRGFY	PTPRF	1196	P10586
FTYSNGETKYVDLTK	OSBPL11	641	Q9BXB4
DKLLGEKLQYYYSSS	PDCL	6	Q13371
DKGSYFGSLVQDYKV	RIN3	611	Q8TB24
GDYKETQYSFKQVFG	KIF23	66	Q02241
NKDGTYTVKFYDGVV	PHF20	111	Q9BVI0
KVGTSDKTKYYLQDG	IGF2R	2206	P11717
SKRNGKAYASGYDET	TSGA10IP	351	Q3SY00
KKGREYALLGNYDSS	KATNAL1	11	Q9BW62
GGGSRLYYSFKNITK	SOX11	306	P35716
LFSKYGKLYSKAGQI	SPATA17	346	Q96L03
LAGTSLGAKLKYESY	SULT6B1	286	Q6IMI4
EKDYTGAAVLYSKGV	SMYD4	81	Q8IYR2
YSDLYFGSDKEKSQI	SLC9C1	386	Q4G0N8
NYYKKLFGSGTTLVV	TRGJ1	1	A0A075B6S0
KLKYSVAFYSLDGVG	LAMA1	1236	P25391
EKDSYGYIFLSNKDG	HEPH	761	Q9BQS7
KYSSLNLFDTYKGKS	PRRC2A	16	P48634
IALVGKYTKFSDSYA	CTPS1	301	P17812
SLYFYQRAGKSLGQK	SHOC1	1381	Q5VXU9
LGTKLKYEVDTSGIY	ST8SIA5	126	O15466
YGIESFSNKTKGYSE	ST8SIA6	86	P61647
SLIAVFQKYAGKDGY	S100A11	16	P31949
GKDGYNYTLSKTEFL	S100A11	26	P31949
SSKLYKYGDINFDDL	RDH14	191	Q9HBH5
YYTKLQGKSLFGFSG	SEZ6L2	866	Q6UXD5
YGTILTDGKDAYTKE	L3HYPDH	241	Q96EM0
YDGFLKTYETASLKS	ABCB7	356	O75027
SYKTDLETAFRKGYG	ADGRF5	196	Q8IZF2
KSYKGLFYFLGSIVN	CLTCL1	706	P53675
AYYVTGKGGLTQDLK	COA7	76	Q96BR5
NSFFYDKLRTKGYDG	SENP3	426	Q9H4L4
QTKYFQGKYGDLDSS	TOP3B	196	O95985
KKYQDSEGLYYLAGT	TNRC18	2936	O15417
GAYKELVTFAKYILG	TIMELESS	761	Q9UNS1
EYNGYGKSLLSTKQE	ZNF567	161	Q8N184
SGVEYSEYNKSGKAL	ZFP1	151	Q6P2D0
ATGSKSLYYYGVKDL	TRAM1L1	66	Q8N609
KGLYLETEAGYYKLS	VWF	116	P04275
TLKGCTLLFYETYGK	TIAM2	541	Q8IVF5
YSYKKDGIGLDLENS	SLFN12L	86	Q6IEE8
YSGLFDKYLGAATSL	SLC5A2	226	P31639
TDDGKVGLYDTYSNK	GEMIN5	446	Q8TEQ6
KKNDSGIYYVGIYSS	SLAMF7	96	Q9NQ25
TAREKGKYSGDYFTL	USP9Y	1366	O00507
GQLLKSTEKYSDFYF	PKD2L2	346	Q9NZM6
SPDGKYLASGSFDKY	TBL1Y	461	Q9BQ87
SSKEGTYAKLGGLYT	PRAG1	946	Q86YV5
GASIFNGQKKVLYYA	RALGAPB	1241	Q86X10
NKGIYKGDRESSGKY	TMED2	66	Q15363
TKSGASYAYILEAFG	SLC7A6	106	Q92536
SEFKAKGYLALGLTY	TTC7B	466	Q86TV6
INLGEGSYAKVKSAY	TSSK1B	16	Q9BXA7
EYQTKLEFALKLGYS	ZC3H12C	161	Q9C0D7
KYFQGTEGTRKASYV	RPTN	596	Q6XPR3
TDYGTTYEKLNDKVG	SORCS1	211	Q8WY21
KGISYYIGAQSNFTK	SLC6A14	291	Q9UN76
KSKGYGFVSFYNKLD	TIAL1	136	Q01085
KDLYDIFYSSGGKGA	ZNF318	1566	Q5VUA4
YLNYEDGKFSKSRGV	MARS1	586	P56192
VEFQNKFYSGTGYKL	TCIRG1	806	Q13488
YYASAGLLKVSEGSK	YEATS2	86	Q9ULM3
SYTDKYFNKLKGGLL	VPS13D	351	Q5THJ4
ASEYKYKEGFRKQLG	NEB	2546	P20929
FSYDLYLVTNGKHGK	GRIN2C	471	Q14957
FSYDLYLVTNGKHGK	GRIN2D	501	O15399